Scholar Rock Holding (SRRK) return on equity (ROE)

Return on equity · fiscal 2025
-154.0%

Scholar Rock Holding (SRRK) earned a return on equity of -154.0% in fiscal 2025 (the year ended December 31, 2025). That is 87.1 percentage points lower than the -66.8% of fiscal 2024. Figures as of 18 Nov 2026, 00:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
-154.0%
Change on fiscal 2024
−87.1 pts
Highest on record
-33.2%fiscal 2020
Lowest on record
-154.0%fiscal 2025
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Scholar Rock Holding return on equity (ROE), in more detail

Across the 8 fiscal years on record (2018–2025), the highest was -33.2% in fiscal 2020 and the lowest -154.0% in fiscal 2025. The fiscal 2025 figure is no higher than in any of the 7 earlier fiscal years on record, whose median is -51.7%.

History · 8 fiscal years

Return on equity by fiscal year

Scholar Rock Holding return on equity (ROE), year by year

Scholar Rock Holding (SRRK) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2025-154.0% 87.1 pts down
2024-66.8% 6.8 pts up
2023-73.6% 21.9 pts down
2022-51.7% 24.9 pts up
2021-76.6% 43.4 pts down
2020-33.2% 12.0 pts up
2019-45.2% 1.1 pts up
2018-46.3%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Scholar Rock Holding and comparable companies
CompanyReturn on equityFiscal year
Belite Bio BLTE-10.1%2025
Ligand Pharmaceuticals LGND12.2%2025
Scholar Rock Holding SRRK-154.0%2025
Teleflex TFX-29.0%2025
Mirum Pharmaceuticals MIRM-7.4%2025
Veradermics MANE-48.8%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SRRK

Scholar Rock Holding, figure by figure

Scholar Rock Holding (SRRK) overview: price, valuation and scorecardAll health care companies by market value

Scholar Rock Holding return on equity (ROE): questions and answers

What is Scholar Rock Holding's return on equity?

Scholar Rock Holding (SRRK) earned a return on equity of -154.0% in fiscal 2025 (the year ended December 31, 2025). That is 87.1 percentage points lower than the -66.8% of fiscal 2024.

Is Scholar Rock Holding's return on equity high or low compared with its own history?

The fiscal 2025 figure is no higher than in any of the 7 earlier fiscal years on record, whose median is -51.7%.

What are the highest and lowest return on equity figures on record for Scholar Rock Holding?

Across the 8 fiscal years on record (2018–2025), the highest was -33.2% in fiscal 2020 and the lowest -154.0% in fiscal 2025.

How is Scholar Rock Holding's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Scholar Rock Holding (SRRK) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/SRRK/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.